期刊文献+

抗体介导的靶向给药系统研究进展 被引量:1

Advances in Antibody-Mediated Targeting Drug Delivery System
下载PDF
导出
摘要 本文简要综述了抗体介导的靶向给药系统的研究进展,包括抗体与药物的直接偶联、纳米粒、脂质体等的原理、特性以及药动药效学研究现状,并对其可行性和前景进行了分析。抗体介导的靶向给药系统不仅可以提高不溶或难溶性药物的溶解度,而且也可以提高靶部位的药物浓度,降低药物对全身各组织的毒副作用,增强对病变组织的治疗效果,为开发更高靶向效率、安全、经济、多类型的给药系统提供了借鉴。 In this paper, the research progress of antibody-mediated targeting drug delivery system, including the targeting principal, efficiency, pharmacokinetics as well as pharmacodynamics of antibody drug conjugates, nanoparticles and liposomes, were summarized. Its feasibility and prospect in drug delivery system were analyzed. Antibody-mediated targeting drug delivery system not only improves the solubility of insoluble or poorly soluble drugs, but also accumulates the drug at targeted sites, increases the therapeutic effect of lesion and decreases toxicity. It can help for the development of kinds of targeted drug delivery system with high targeting efficiency, safety and economy.
出处 《生物技术通讯》 CAS 2017年第2期196-201,共6页 Letters in Biotechnology
关键词 抗体 靶向 纳米粒 脂质体 抗体药物偶联 antibody target nanoparticles liposomes antibody drug conjugates
  • 相关文献

参考文献3

二级参考文献33

  • 1潘弘,牛国琴,潘俊,陆伟跃.人鼠嵌合抗肿瘤细胞核单抗-空间稳定脂质体的制备及其体外靶向(英文)[J].药学学报,2006,41(6):506-512. 被引量:10
  • 2叶果,柯爱武,李羲.MRK-16修饰阿霉素免疫脂质体逆转肺癌细胞多药耐药研究[J].现代肿瘤医学,2007,15(6):754-757. 被引量:9
  • 3Simard P, Leroux J C. pH-sensitive immunoliposomes specific to the CD33 cell surface antigen of leukemic cells[J]. Int JPharm, 2009, 381(2): 86-96.
  • 4Karve S, Alaouie A, Zhou Y, et al. The use of pH-triggered leaky heterogeneities on rigid lipid bilayers to improve intracellular trafficking and therapeutic potential of targeted liposomal immunochemotherapy[J]. Biomaterials, 2009, 30(30): 6055-6064.
  • 5Gunawan R C, Auguste D T. The role of antibody synergy and membrane fluidity in the vascular targeting of immunoliposomes[J]. Biomaterials, 2010, 31(5): 900-907.
  • 6Cheng W W, Allen T M. Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: A comparison of whole monoclonal antibody, Fab' fragments and single chain Fv[J]. J Control Release, 2008, 126(1): 50-58.
  • 7钟延强,钟威,郭亚军,等.Trastuzumab修饰的包裹毒素蛋白的PEG化免疫脂质体及其制备与应用:CN.101536982ALP].2009-4-27.
  • 8Pattillo C B, Venegas B, Donelson F J, et al. Radiation- Guided Targeting of Combretastatin Encapsulated Irnmunoliposomes to Mammary Tumors[J]. Pharm Rex, 2009, 26(5): 1093-1100.
  • 9Elbayoumi T A, Torchilin V P. Tumor-specific antibody- mediated targeted delivery of Doxil reduces the manifestation of auricular erythema side effect in mice[J]. lnt JPharm, 2008, 357(1-2): 272-279.
  • 10Yang W, Barth R F, Wu G, et al. Boron neutron capture therapy of EGFR or EGFRvlII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as moleculartargeting agents[J]. Appl Radiat Isot, 2009, 67(7-8 Suppl): $328-331.

共引文献20

同被引文献10

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部